Last week, I wrote about US President Donald Trump’s administrative self-coup (or autogolpe) — his orders to the executive ...

Nicolas Hieronimus calls on political leaders to act to prevent a deepening of economic divergence from the US ...

On Sunday, Crown Prince Mohammed bin Salman welcomed Syria’s new interim president, Ahmed al-Sharaa, in Riyadh. Barely three months ago, Riyadh had hosted former president Bashar al-Assad, now in ...

Republican attorneys-general from more than a dozen US states have accused BlackRock, Goldman Sachs and JPMorgan of misrepresenting the risks of investing in China, including the possibility of a ...

Her specialism is occasionwear from the big French designers, and she has one of the most extensive collections of vintage Chanel out of any vintage shop in Paris (the brand’s Foundation recently came ...

Trump administration move to temporarily shutter US agency triggers crisis for independent outlets in ex-Soviet space ...

Marks and Spencer has appointed the former head of Boohoo to run its clothing, home and beauty divisions as the retailer presses ahead with its turnaround.

Axel Rudakubana’s referral to the UK counterterrorism scheme was closed prematurely, three years before he murdered three ...

Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley also ...

The Bank of England has halved its 2025 growth forecast and cut interest rates by a quarter-point to 4.5 per cent, as it contends with a stagnant UK economy and an increasingly uncertain international ...

Bombardier separately announced strong results for the fourth quarter, with full-year revenues rising 8 per cent to $8.7bn, driven by a record performance in its services business, and 146 aircraft ...

The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...